Skip to content

Long Term Follow-up of Persistent Pain, Sensory Disturbances and Lymphedema After Breast Cancer Treatment

Long Term Follow-up of Persistent Pain, Sensory Disturbances and Lymphedema After Breast Cancer Treatment

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01543711
Enrollment
2411
Registered
2012-03-05
Start date
2012-01-31
Completion date
2012-04-30
Last updated
2013-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Lymphedema, Neuropathy, Pain, Post Operative Pain

Keywords

Breast cancer, persistent pain, neuropathic pain, lymphedema

Brief summary

Persistent pain, sensory disturbances, lymphedema and functional impairment are frequently occurring late effects of breast cancer treatment. The investigators have previously published data on 3253 women treated for breast cancer in Denmark in the period 2005-2006. Very few studies have examined how these late effects change in time. The aim of this study is to examine in a well defined patient population any change in the prevalence of persistent pain, sensory disturbances, lymphedema and functional impairment, as well as risk factor profile.

Interventions

None listed

Sponsors

Danish Cancer Society
CollaboratorOTHER
Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with primary breast cancer between 2005-2006 * Participated in a study in 2008

Exclusion criteria

* Recurrent or new primary cancer * Metastatic cancer * Reconstructive surgery

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of persistent pain6-7 years post operativePrevalence of pain in the breast area, axilla, side of chest or arm, as a yes/no variable
Prevalence of patients changing pain status from the 2008 survey6-7 years

Secondary

MeasureTime frame
Prevalence of functional impairment6-7 years
Risk factors associated for persistent pain, sensory disturbances, lymphedema or functional impairment6-7 years
Prevalence of sensory disturbance6-7 years
Risk factors associated to changing status of sensory disturbances and lymphedema6-7 years post operative
Prevalence of patients changing status of sensory disturbances and self reported lymphedma6-7 years
Prevalence of self reported lymphedma6-7 years

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026